U.S. Auto Stock News

Wondering if Weibo stock is a hidden bargain or a value trap? Let’s quickly unpack what’s been happening and where it might go from here. Weibo’s share price moved up 0.9% over the last week, but it’s still down 14.4% over the past month, keeping investors alert to both growth potential and risks. Recent headlines have spotlighted renewed interest in Chinese tech stocks amid regulatory shifts and fresh partnership announcements from industry players. This backdrop of evolving sentiment is...

MGIC Investment recently drew market attention after reporting early signs of improvement in the U.S. mortgage market, including declining mortgage rates, better housing inventory, and increasing purchase applications. A unique aspect of the announcement is the company’s continued commitment to share repurchases, signaling strong management confidence and a focus on returning capital to shareholders. We'll examine how management’s decision to maintain significant share buybacks could...

Capricor Therapeutics, Inc. found itself at the center of market turbulence after well-known investor Martin Shkreli disclosed a short position targeting the company’s lead drug, Deramiocel. Shkreli also raised doubts about its clinical prospects. See our latest analysis for Capricor Therapeutics. This controversy has only sharpened focus on Capricor’s turbulent run. While the share price saw a sharp one-day rebound of 12.8%, longer-term momentum remains weak with a year-to-date share price...

Kura Oncology recently attracted attention after KOMZIFTI, its once-daily oral menin inhibitor, secured full FDA approval for adults with relapsed or refractory acute myeloid leukemia with a susceptible NPM1 mutation. This milestone addresses a treatment gap in AML care. See our latest analysis for Kura Oncology. Kura Oncology’s momentum has picked up meaningfully after KOMZIFTI’s approval, with the share price up over 48% in the past three months and 38% year-to-date. While recent investor...

If you are wondering whether KKR stock is looking like a value play or a value trap, you are not alone. It is a big question for many investors right now. Recently, KKR’s stock has seen a modest rebound of 2.8% over the past week, though it remains down 1.2% over the last month and is down 19.0% year-to-date, with a longer-term 1-year return of -24.1%. The 3-year and 5-year returns are still very strong at 138.2% and 221.9% respectively. Plenty of headlines have kept KKR in the spotlight...

Workday recently reported its third-quarter fiscal 2026 results, showcasing subscription revenue of US$2.43 billion and a net income of US$252 million, while also raising its full-year and fourth-quarter guidance as AI-powered products gain traction and recent acquisitions bolster its offerings. More than 75% of Workday's core customers are now using its AI-driven solutions, underlining a rapid shift toward AI adoption within enterprise cloud applications and contributing to strong operating...

Main Street Capital (MAIN) has caught the spotlight following news of its upgraded valuation grade and strong financial results. Investors are taking note of the company’s steady record of shareholder returns and distinctive approach within the Business Development Company sector. See our latest analysis for Main Street Capital. Main Street Capital’s share price has recently seen modest ups and downs, but the bigger story is its standout long-term record. Despite a slight dip in the past...

Thinking about whether Haemonetics is a savvy investment right now? Let’s dive into what the market is signaling and where the opportunity may lie for new and existing investors. Haemonetics’ stock has seen notable swings recently, soaring 57.7% over the last month and climbing 7.4% just this past week. These moves draw attention when considering both growth and evolving risk perceptions. The recent price surge comes on the back of news highlighting the company’s expansion in innovative...

On November 18, 2025, Ardent Health, Inc. (NYSE:ARDT) announced the authorization of a share repurchase program of up to US$50 million, to be funded from existing cash resources and not expected to affect its ability to pursue strategic growth opportunities or mergers and acquisitions. This buyback initiative highlights the company's solid financial position and its intention to prioritize shareholder value while maintaining flexibility for future expansion. We'll explore how the newly...

If you have ever wondered whether Hawkins is a hidden bargain or trading at a premium, you are in the right place. Let's break down what really matters when assessing value. Shareholders have seen a rollercoaster lately, with the stock jumping 5.1% over the last week but still down 22.7% in the past month. Over the long haul, Hawkins has posted a massive 442.0% return across five years. In the past few weeks, Hawkins has attracted attention thanks to industry partnerships and strategic...

Steelcase (SCS) stock has moved slightly this week, catching the attention of investors who track value in the commercial services sector. The company's performance over the past month and year sets an interesting backdrop for its recent price activity. See our latest analysis for Steelcase. Steelcase’s share price has gained serious momentum this year, with a year-to-date price return of nearly 39% reflecting renewed optimism around its growth trajectory. After steady advances and a robust...

Fastenal (FAST) has caught investor attention after its latest earnings showed an 11.7% jump in revenue over last year, even though earnings per share landed just under expectations. The company also welcomed a new Chief Financial Officer, Max Tunnicliff, earlier this month. See our latest analysis for Fastenal. Riding a wave of robust revenue growth alongside some leadership changes, Fastenal’s share price currently stands at $40.30. While the recent 90-day price return has dipped nearly...

Veeva Systems (VEEV) just posted its third quarter results, recording healthy jumps in revenue and net income compared to last year. In addition, the company expanded its relationship with Roche Pharmaceuticals, which selected Veeva Vault CRM for its commercial activities. See our latest analysis for Veeva Systems. The recent boost from strong earnings and the expanded partnership with Roche initially sparked optimism for Veeva Systems, but the company’s share price return has faced pressure,...

In recent days, ACM Research announced the delivery of its first Ultra Lith Baker lithography system to a major global display panel manufacturer and its inaugural Ultra ECP ap-p electrochemical plating tool to a panel fabrication customer. These technology deployments highlight ACM’s efforts to address advanced lithography and packaging challenges, reflecting customer demand for higher process precision, greater flexibility, and scalable manufacturing in the semiconductor industry. Next,...

Arhaus (ARHS) has attracted attention following recent trading activity, as shares saw moderate gains over the past week. Investors seem to be weighing the company's steady position in the home furnishings sector in light of broader market shifts. See our latest analysis for Arhaus. Arhaus’s recent share price jump, capped by an impressive 18% return over the last week, has caught the eye of investors. While the 1-year total shareholder return sits at a modest 3.8%, momentum appears to be...

Futu Holdings (NasdaqGM:FUTU) stock caught investors’ attention recently as it continued to show sharp swings over the past month. The company’s shares are navigating a volatile period, prompting many to revisit its underlying business fundamentals. See our latest analysis for Futu Holdings. After a blockbuster year capped by a 113.44% year-to-date share price return, Futu Holdings continues to see lively trading action. While recent weeks brought some pullback, momentum remains well ahead of...

Wondering if W. R. Berkley is trading at a bargain or getting pricey? Let’s dig into what’s really driving its value right now. The stock is on the move, climbing 1.2% over the past week and an impressive 33.8% year-to-date. This hints at renewed investor optimism or changing risk appetites. Much of this momentum has been fueled by upbeat industry-wide outlooks and W. R. Berkley’s recent moves to expand its specialty insurance offerings. These developments have caught investor attention and...

Incyte's recent performance is catching attention after the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a positive opinion recommending approval of Minjuvi for relapsed or refractory follicular lymphoma. This regulatory milestone expands the drug’s commercial opportunity in Europe, which investors are watching closely. See our latest analysis for Incyte. After the EMA’s positive opinion on Minjuvi, Incyte's share price momentum has accelerated, with a...

Penguin Solutions (PENG) announced expanded support for NVIDIA’s latest high-performance GPUs within its OriginAI platform, as well as a new ICE ClusterWare software release. These developments highlight Penguin’s focus on addressing major enterprise AI infrastructure needs. See our latest analysis for Penguin Solutions. Penguin Solutions’ string of announcements around OriginAI and ICE ClusterWare has certainly caught the market’s attention, with the stock enjoying a 1-day share price return...

On November 20, 2025, NIKE, Inc.’s Board of Directors announced a 3 percent increase in its quarterly cash dividend to $0.41 per share, payable on January 2, 2026, to shareholders of record as of December 1, 2025. This dividend increase marks NIKE’s ongoing commitment to returning capital to shareholders, reflecting confidence in its cash generation and outlook. We’ll examine how NIKE’s decision to raise its dividend signals board confidence and impacts the company’s broader investment...

Zebra Technologies (ZBRA) shares have seen notable swings over the past month, losing nearly 19%. Investors are closely watching company fundamentals and broader tech trends to gauge where the stock could move next. See our latest analysis for Zebra Technologies. Zooming out, Zebra Technologies’ 1-year total shareholder return stands at -38.3%, reflecting persistent pressure despite occasional short-term rebounds such as last week’s 8.5% share price recovery. Recent momentum has faded after a...

Citizens has reiterated its stance on Diversified Healthcare Trust (DHC) after the company reported third-quarter results, highlighting increasing occupancy in senior housing properties and transparent efforts to tackle high-cost debt through asset sales and credit facilities by early 2026. See our latest analysis for Diversified Healthcare Trust. Momentum has clearly shifted for Diversified Healthcare Trust. After months of strategic moves and improved occupancy across its senior housing...

SM Energy (SM) has been on the radar for investors keeping tabs on independent oil and gas producers. The company has seen mixed performance over the past month. This has prompted a closer look at its value and operations in Texas. See our latest analysis for SM Energy. After a tough start to the year, SM Energy’s share price has pulled back considerably with a year-to-date decline of 53.36% and a one-year total shareholder return of -56.92%. While momentum has faded, long-term investors may...

Granite Construction (GVA) just posted third-quarter earnings per share that topped forecasts, even as revenue came in a bit light. Investors are paying close attention as the company retools its strategy, moving away from higher-risk projects and increasing its focus on the Materials business through acquisitions and organic growth. See our latest analysis for Granite Construction. Reflecting these strategy shifts and solid earnings, Granite Construction’s share price has climbed 21%...